Document Preview Unavailable

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Waks, Adrienne G; Cohen, Ofir; Bose Kochupurakkal; Kim, Dewey; Dunn, Connor E; et al.  bioRxiv, Nov 10, 2019.

You might have access to this document